Chimeric Therapeutics Limited

CHMMF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$8-$3-$15$2
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$0
Change in WC-$0$0$4$0
Other Non-Cash$2-$1$9-$8
Operating Cash Flow-$5-$3-$3-$5
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0-$0$0
Investing Cash Flow-$0$0-$0$0
Financing Activities
Debt Repay.$0-$0$0-$1
Stock Issued$0$0$4$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$5$2$7
Financing Cash Flow$5$5$2$6
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$5$5-$0-$2
Supplemental Information
Beg. Cash$5$0$4$5
End Cash$0$5$3$4
Free Cash Flow-$5-$3-$3-$5
Chimeric Therapeutics Limited (CHMMF) Financial Statements & Key Stats | AlphaPilot